0001213900-24-008559.txt : 20240131
0001213900-24-008559.hdr.sgml : 20240131
20240131182858
ACCESSION NUMBER: 0001213900-24-008559
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240129
FILED AS OF DATE: 20240131
DATE AS OF CHANGE: 20240131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shenouda Maged
CENTRAL INDEX KEY: 0001658369
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39082
FILM NUMBER: 24584365
MAIL ADDRESS:
STREET 1: 305 WEST 18TH STREET, APT 4B
CITY: NEW YORK
STATE: NY
ZIP: 10011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RELMADA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001553643
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 455401931
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2222 PONCE DE LEON BLVD. 3RD FLOOR
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: 646 876 3459
MAIL ADDRESS:
STREET 1: 2222 PONCE DE LEON BLVD. 3RD FLOOR
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CAMP NINE, INC.
DATE OF NAME CHANGE: 20120706
4
1
ownership.xml
X0508
4
2024-01-29
0
0001553643
RELMADA THERAPEUTICS, INC.
RLMD
0001658369
Shenouda Maged
C/O RELMADA THERAPEUTICS, INC.
2222 PONCE DE LEON BLVD, 3RD FLOOR
CORAL GABLES,
FL
33134
0
1
0
0
Chief Financial Officer
0
Common Stock
2024-01-29
4
P
0
10800
3.6528
A
13028
D
Common Stock
2024-01-30
4
P
0
15000
3.8882
A
28028
D
Common Stock
2024-01-31
4
P
0
6875
4.0645
A
34903
D
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
Purchase prices range from $3.57 to $3.745 per share, inclusive.
Purchase prices range from $3.82 to $3.90 per share, inclusive.
Purchase prices range from $3.95 to $4.18 per share, inclusive.
/s/ Maged Shenouda
2024-01-31